FDA reverses decision to halt compounding of Terzepetide, for now
The Weight Loss Podcast por Bob Weigert & Julie Almandine
T4 · E8
28 oct 2024
11:16
Notas del episodio
Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.
Palabras clave
shortage
compounded medications
branded medications
Terzepitide
manufacturing
FDA
stop manufacture
consequences
reversal